Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
cancer
life sciences
national
3
×
national blog main
novartis
bristol-myers squibb
cancer immunotherapy
samit hirawat
abbvie
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
biontech
boehringer ingelheim
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
dyne therapeutics
eli lilly
escape bio
escient pharmaceuticals
What
company’s
3
×
pipeline
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
corporation
diversity
hirawat
medical
myers
myers’s
officer
progress
scrip
spoke
squibb
trial
year
acquisitions
biggest
bio
build
buy
ceo
daniel
debut
drug
dyne’s
gilead
microbiome
moves
openly
o’day
roundup
sciences
Language
unset
Current search:
company’s
×
national
×
photo
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More